NCT06055218View on ClinicalTrials.gov

COVID-19 Novel Molecular Point of Care Diagnostics Evaluation

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

April 11, 2023

Study Completion Date

August 30, 2023

Conditions
COVID-19 Respiratory Infection
Trial Locations (3)

1211

University Hospital of Geneva, Geneva

759125

Central Public Health Laboratories, Kampala

L35QA

Liverpool school of Topical Medicine, Liverpool

All Listed Sponsors
lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER